Lonza nominates Pearl Huang and Lonza Group stock costs EUR 612.50

Published on 10/09/2026 at 12:15 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Lonza Group stock costs EUR 612.50 on October 9, 2026, after EUR 606.80. H1 2026 sales reached CHF 3.4 billion.

Key points in brief

Lonza nominated Pearl Huang as an independent board member on September 30, 2026.
Half-Year 2026 sales were CHF 3.4 billion and CORE EBITDA was CHF 1.2 billion.
The Lang & Schwarz price was EUR 612.50 on October 9, 2026 at 12:12 p.m. CEST, up 0.94 percent versus EUR 606.80.
Goldman Sachs maintained a Buy rating with a CHF 680.00 target on October 1, 2026.

Schwarz-Weiß-Reportage: Wissenschaftler im Schutzanzug am Mikroskop, dokumentarischer Stil — Lonza CH0013841017 Forscher im Schutzanzug am Mikroskop dokumentarisch in Schwarz Weiss fotografiert, Illustration mit AI erstellt.

Lonza Group (CH0013841017) was trading at EUR 612.50 at Lang & Schwarz on October 9, 2026 at 12:12 p.m. CEST, up 0.94 percent versus the EUR 606.80 prior close. The company nominated Pearl Huang as an independent board member on September 30, 2026, according to EQS News.

Three dated company developments

On September 10, 2026, Lonza announced a commercial spray-drying facility in Bend, Oregon, with completion scheduled for 2029 and more than 80 initial jobs. The project includes two PSD-4 spray-drying units, according to finanzen.ch.

On September 30, 2026, the board nomination added a specific governance milestone. Huang would join two committees if elected at the May 2027 annual meeting, while Lonza said eight new board members had joined since 2024, according to EQS News.

On October 9, 2026, the Lang & Schwarz quote supplied the latest market figure, with the euro price 0.94 percent above its prior close. The move stayed below the 1.00 percent threshold that would support a directional headline, so the stock is presented as a price state rather than a gain narrative.

What does the board change add?

The nomination connects board renewal with pharmaceutical and biotechnology expertise. The company said Huang would be appointed to the Strategy and Innovation Committee and the Remuneration Committee if elected, while two existing directors would not stand for re-election at the 2027 AGM, according to EQS News. For investors, the relevant measure is whether the refreshed board can support Lonza's growth strategy without weakening oversight.

Operating scale provides the financial backdrop. Lonza reported CHF 3.4 billion in sales and CHF 1.2 billion in CORE EBITDA for Half-Year 2026, figures included in the board release by EQS News. The EBITDA figure equals 35.29 percent of sales when calculated from those two reported values, giving the board discussion a measurable operating context.

Analyst target and next dates

Goldman Sachs maintained a Buy rating and a CHF 680.00 price target on October 1, 2026, according to Markets Insider. The target is a separate Swiss-franc reference and is not combined with the euro Lang & Schwarz price.

Lonza's next dated events are the expected fourth-quarter 2026 results on January 27, 2027, reported by finanzen.ch, and the annual general meeting in May 2027, specified in the board release.

Price holds above the prior close

At Lang & Schwarz, Lonza Group stock was trading at EUR 612.50 on October 9, 2026 at 12:12 p.m. CEST, up 0.94 percent versus the EUR 606.80 prior close. The company is listed on the SIX Swiss Exchange under ticker LONN, and the share is included in the SMI.

The further course of trading is shown by the continuously updated real-time quote of Lonza Group stock.